(Q52649284)

5 May 2018

title

Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli. (English)

1 reference

5 May 2018

0 references

0 references

0 references

1 reference

Chun-Liang Lin

1

1 reference

5 May 2018

Yung-Chien Hsu

2

1 reference

5 May 2018

Pei-Hsien Lee

3

1 reference

5 May 2018

Chen-Chou Lei

4

1 reference

5 May 2018

Jeng-Yi Wang

5

1 reference

5 May 2018

Yu-Ting Huang

6

1 reference

5 May 2018

Shao-Yu Wang

7

1 reference

5 May 2018

Feng-Sheng Wang

8

1 reference

5 May 2018

publication date

11 April 2014

1 reference

5 May 2018

Journal of Molecular Medicine

published in

1 reference

5 May 2018

volume

92

1 reference

5 May 2018

issue

7

1 reference

5 May 2018

page(s)

779-792

1 reference

5 May 2018

https://scigraph.springernature.com/pub.10.1007/s00109-014-1125-6

exact match

0 references

cites work

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Pathogenetic mechanisms of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Critical role for osteopontin in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

AMPK mediates the initiation of kidney disease induced by a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-014-1125-6

Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24722948

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24722948

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24722948

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00109-014-1125-6

1 reference

5 May 2018

1 reference

5 May 2018